These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6384959)

  • 1. Atypical depression.
    Silberman EK; Sullivan JL
    Psychiatr Clin North Am; 1984 Sep; 7(3):535-47. PubMed ID: 6384959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open trial of MAO inhibitors in bulimia.
    Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
    J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    Sheehan DV
    Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed clinical approach to chronic and "resistant" depressions: evaluation and treatment.
    Akiskal HS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):32-7. PubMed ID: 3930475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
    Sheehan DV
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):29-36. PubMed ID: 6429129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A history of the concept of atypical depression.
    Davidson JR
    J Clin Psychiatry; 2007; 68 Suppl 3():10-5. PubMed ID: 17348762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new generation of antidepressants.
    Feighner JP
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):49-55. PubMed ID: 6222037
    [No Abstract]   [Full Text] [Related]  

  • 11. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course and treatment of atypical depression.
    Nierenberg AA; Alpert JE; Pava J; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1998; 59 Suppl 18():5-9. PubMed ID: 9840192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacological treatment of panic disorder.
    Bowden CL
    Bull Menninger Clin; 1992; 56(2 Suppl A):A29-41. PubMed ID: 1623338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of personality factors in depression].
    Quitkin FM
    Encephale; 1993 Aug; 19 Spec No 3():491-2. PubMed ID: 8299548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition and diagnosis of atypical depression.
    Thase ME
    J Clin Psychiatry; 2007; 68 Suppl 8():11-6. PubMed ID: 17640153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical depression.
    Davidson JR; Miller RD; Turnbull CD; Sullivan JL
    Arch Gen Psychiatry; 1982 May; 39(5):527-34. PubMed ID: 7092486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
    Lenox RH; Shipley JE; Peyser JM; Williams JM; Weaver LA
    Psychopharmacol Bull; 1984; 20(1):79-82. PubMed ID: 6144136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.